Massive bio company
WebMar 29, 2024 · The company serves more than two dozen pharmaceutical companies, contract research organizations, and hospital networks, and has been awarded an SBIR contract by the National Cancer Institute.... WebMassive Bio is an AI-driven platform connecting cancer patients and their oncologists to bio-pharmaceutical clinical trials that offer new, alternative, and targeted treatments to … If you are a Patient, a Provider, a Pharma, or a company, we can achieve joint … Massive Bio is a free service that helps patients get more out of their health … Massive Bio is a free service that helps patients get more out of their health … Company. About Us Media Center ... Massive Bio’s engine ingests a broad … Company. About Us Media Center ... Massive Bio is an AI-driven platform … Company. About Us Media Center ... Massive Bio is an AI-driven platform …
Massive bio company
Did you know?
WebMassive Bio is an AI-driven platform connecting cancer patients and their oncologists to bio-pharmaceutical clinical trials that offer new, alternativ … See more Massive Bio is a global cutting-edge advisory service for … WebMar 29, 2024 · Massive Bio supports 1,750 clinical sites (650 of these sites are outside United States) and has partnerships with 21 pharmaceutical companies and five clinical research organizations globally ...
WebNov 14, 2024 · Headquartered in New York, Massive Bio is a privately held company that operates in 12 countries. Contacts Massive Bio: Lisa Barbadora, [email protected], +1 610-420-3413 Azra AI: KNB Communications, [email protected], (772) 812-3823 SOURCE: Business Wire Share Article WebOct 30, 2024 · www.massivebio.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Other Healthcare Technology Systems …
WebOct 26, 2024 · NEW YORK-- ( BUSINESS WIRE )-- Massive Bio, a leader in AI-powered cancer clinical trial enrollment, today announced that the company exceeded its goal to … Web113 Likes, 7 Comments - The Hijab Company (@the_hijab_company) on Instagram: "The best color in the world, is the one that looks good on you! 殺 We’ve got your ...
WebDec 7, 2024 · Massive Bio was founded in 2015 and is headquartered in NYC. Massive Bio has a team of 50 people team and was founded by ex-M&A, clinical and technology executives. You can connect with us at [email protected], as well as follow Massive Bio on Twitter, LinkedIn, and Facebook.
WebMassive Bio supports 1,750 clinical sites (650 of these sites are outside the United States) and has partnerships with 21 pharmaceutical companies and five clinical research … baker hughes drilling fluid abu dhabiWebApr 12, 2024 · Company. About Us Media Center ... Massive Bio is an AI-driven platform connecting cancer patients and their oncologists to bio-pharmaceutical clinical trials that offer new, alternative, and targeted treatments to help create positive patient outcomes. Reach Us. [email protected] baker hughes careers saudi arabiaWebwww.massivebio.com Contact Information Headquarters 90 West St, New York City, New York, 10006, United States (844) 627-7246 Massive Bio Profile and History Massive … baker hughes dallas txWebMassive Bio serves nearly two dozen pharmaceutical companies and contract research organizations (CROs) providing patient recruitment, site selection and real-world data … aravindan periakaruppanWebMassive Bio Magazine Comes to Life News July 7, 2024 Conferences & Education Sessions News June 3, 2024 Massive Bio Raises $9 Million To Scale Gro... Join our community and receive our newsletter Join the newsletter AI technology matches you to clinical trials Pre-screens for 30k clinical trials Finds trials near you baker hughes dhahran baseWebOct 26, 2024 · NEW YORK, October 26, 2024 -- ( BUSINESS WIRE )-- Massive Bio, a leader in AI-powered cancer clinical trial enrollment, today announced that the company exceeded its goal to onboard 100,000... baker hughes dataWebMar 22, 2024 · Massive Bio, Inc., a private AI-enabled oncology startup that provides virtual and in-person concierge services for cancer patients, and NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, today announced a collaboration with the goal of accelerating … baker hughes dubai